People Nielka van Erp

Contact

dr. Nielka van Erp

+31 (0)24 361 64 05
contact

Nielka van Erp associate rofessor

Nielka van Erp's research activities lie in the field of the pharmacology of targeted oncolytics and the use of pharmacology to individualize and optimize cancer treatment.

read more

Nielka van Erp associate rofessor

Over the past years Nielka has established a cancer pharmacology research group at the department of Pharmacy in the Radboudumc that is (inter)nationally recognized for its academic achievements in two domains: Dose individualization in oncology by connecting biomarker response to drug exposure. The clarification of diversity in treatment response by combining pharmacokinetics of the anticancer drugs and biomarkers is a unique approach, leading to further understanding of response diversity. The pioneer work in this research domain resulted in international invitational lectures and workshops, honored research grants, and international collaborations. Pharmacological strategies proven feasible and safe to make oncolytic therapy better tolerable and affordable. Dose optimization by adjusting the dose based on interpatient differences in exposure will optimize treatment outcomes. Furthermore, pharmacological interventions (e.g. intake with food) can optimize the exposure while using a reduced dose. Such pharmacological interventions are easily implemented in clinical practice and have a major impact on health care costs. Our research resulted in invitations for lectures on multiple international meetings, honored grant proposals, uptake into treatment guidelines and received media attention. The research resulted in the successful completion of several PhD thesis's and the recruitment of other PhDs to continue this work. As a hospital pharmacist and clinical pharmacologist

Research group Translational CRC research

Daniele Tauriello's, Henk Verheul's, Nielka van Erp's and Iris Nagtegaal's research group is a cross-disciplinary research collaboration of four Radboudumc groups, with the aim of advancing clinical translation for colorectal cancer.

read more

Research group Clinical pharmacology

Nielka van Erp's research group aims to optimize anticancer treatment in oncology patients by recognizing and addressing interindividual differences and by developing approaches to keep the drugs available for all patients suffering from cancer.

read more

Personal prizes & awards national & international

  • 2009: Merit Award Recipient, for submitting a top-ranking abstract selected for presentation at ASCO 2009
  • 2007: Merit Award Recipient, for submitting a top-ranking abstract selected for presentation at ASCO 2007
read more

Personal prizes & awards national & international

  • 2009: Merit Award Recipient, for submitting a top-ranking abstract selected for presentation at ASCO 2009
  • 2007: Merit Award Recipient, for submitting a top-ranking abstract selected for presentation at ASCO 2007
  • 2005: Grant "KWF stagebeurs voor academici", for visit to Johns Hopkins
  • 1999: Grant "KWF stagebeurs voor studenten", for visit to UCSD

Field of study

Clinical Pharmacy

Radboud Institute for Health Sciences

Ideally, every procedure in clinical practice and public health should take place based on proof, instead of intuition or 'experience'. Our aim is to innovate and personalize healthcare and public health. read more